LUYE PHARMA

02186

1.6352.97% ( -0.050 )

Delay Closed: Nov 12, 16:08:06

Current ValuationThe current P/E ratio is 8.15, below the reasonable range, cheaper than 84.2% of the time in the past 5 years, and the industry ranks 9/53, the industry Median 6.81.

8.15xP/E

Stock priceHK$1.64Earnings per shareHK$0.20

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

Industry median 6.81x

010203040

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

Industry median 6.81x

0x20x40x60x80x100x

P/E ratio
Name/Symbol
03320HKCHINARES PHARMA	5.88x	7.23%	HK$28.11B
01681HKCONSUN PHARMA	9.79x	20.92%	HK$13.24B
02186HKLUYE PHARMA	8.15x	47.27%	HK$6.53B
02877HKSHINEWAY PHARM	6.81x	16.89%	HK$6.31B
02633HKJACOBSON PHARMA	6.10x	1.99%	HK$1.84B
08049HKJILIN CHANGLONG	6.34x	--	HK$1.60B
02348HKDAWNRAYS PHARMA	5.10x	--	HK$1.37B
02161HKJBM HEALTHCARE	6.32x	6.78%	HK$1.27B
00239HKPAK FAH YEOW	7.46x	--	HK$738.59M
00950HKLEE'S PHARM	5.16x	--	HK$618.28M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.